FDA approves Sanofi/Regeneron cholesterol drug with limits
The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a
Continue Reading http://www.reuters.com
Join the Discussion